Bio-Pharm
D&D Pharmatech "Confident in MASH and Obesity Drug Efficacy…Targeting 100 Trillion Won Market"
“The GLP-1 obesity treatment market is expected to grow to 100 trillion won( approximately 77 billion dollars) by…